LAS VEGAS, NV—In the United States, TAVR has always been mandated as a two-operator procedure—the Centers for Medicare & Medicaid Services (CMS) requires one interventional cardiologist and one ...

While there are several ways to replace your aortic valve, TAVR and SAVR differ significantly in their approach and recovery. TAVR is a procedure, while SAVR is a surgery. “There will be ...

Meeting Coverage > TCT EP Study During TAVR Offers Better Prediction of Late Conduction Disturbances — Interventional cardiologists trained to handle His bundle recordings at one center by ...

LONDON, England—Treatment with the self-expanding Evolut PRO/R transcatheter heart valve (Medtronic) for severe symptomatic aortic stenosis significantly improves hemodynamics and effectively enlarges ...

People didn't have to wait long after transcatheter aortic valve replacement (TAVR or TAVI) to safely undergo noncardiac surgery, though suboptimal device performance should give pause for another ...

A transcatheter aortic valve replacement (TAVR) procedure replaces a damaged aortic valve with a new one. TAVR is minimally invasive and may improve quality of life.

Key takeaways: TAVR was superior to clinical surveillance in patients with asymptomatic severe aortic stenosis. Almost all patients in the clinical surveillance group eventually needed TAVR.

TAVR, or transcatheter aortic valve replacement, is a minimally invasive procedure to replace a narrowed aortic valve that fails to open properly.

The TAVR procedure involves a multidisciplinary team of healthcare professionals, including implanting cardiologists, heart surgeons, Cath-Lab nurses, radiology technicians and anesthesiologists.

CHICAGO — Among patients with severe aortic stenosis at low surgical risk, transcatheter aortic valve replacement and surgery conferred similar rates of death and disabling stroke at 5 years ...

In a trial that many are calling landmark, transcatheter aortic valve replacement had better outcomes than surveillance for patients with severe but asymptomatic aortic stenosis.

“Following Edwards Lifesciences’ announcement of an expected 5% growth for its transcatheter aortic valve replacement (TAVR) business, GlobalData observes hopeful signs of resiliency in the ...